Lv1
50 积分 2023-12-13 加入
Taiwan GEST-TASL-TMASO Joint Position Statement in Managing Metabolic Dysfunction-Associated Steatotic Liver Disease and Obesity
2天前
已关闭
Nonclinical Development of Oligonucleotide-Based Therapeutics: Insights from an IQ DruSafe ONT Working Group Survey
18天前
已完结
GLP-1 and MASH: When weight loss isn't the whole story
20天前
已完结
The weight-loss-independent hepatoprotective benefits of semaglutide are orchestrated by intrahepatic sinusoidal endothelial GLP-1 receptors
20天前
已完结
Current therapeutic landscape and future treatment perspectives of MASH
22天前
已完结
Dyslipidaemia and hepatic steatosis: mechanisms and implications for lipid-lowering therapy
22天前
已完结
The evolving landscape of drug targets
1个月前
已完结
Molecular mechanisms and pathogenesis of MASH
1个月前
已完结
Towards a reference cell atlas of liver diversity over the human lifespan
1个月前
已完结
A cross-organ single-cell analysis of hypertension
2个月前
已完结
皖公网安备34019202002308
